MaxCyte
Provider of non-viral electroporation platforms, consumables, and laboratory services for research, discovery and clinical-scale cell and gene therapy manufacturing. Offers scalable static and flow electroporation systems, GMP-compatible consumables and process support, sequencing-based off-target assessment workflows for genome editing (including base editors), and regulatory documentation support to assist IND/CTA/BLA submissions.
Industries
Nr. of Employees
medium (51-250)
Patents
Engineering and delivery of therapeutic compositions of freshly isolated cells
US-10660917-B2
View DetailsEngineering and delivery of therapeutic compositions of freshly isolated cells
US-9669058-B2
View DetailsEngineering and delivery of therapeutic compositions of freshly isolated cells
US-9132153-B2
View Details
Engineering and delivery of therapeutic compositions of freshly isolated cells
US-10660917-B2
View DetailsEngineering and delivery of therapeutic compositions of freshly isolated cells
US-9669058-B2
View DetailsEngineering and delivery of therapeutic compositions of freshly isolated cells
US-9132153-B2
View DetailsProducts
Electroporation instruments (static and flow platforms)
Laboratory and manufacturing instruments enabling transfection of primary cells, cell lines and large cell batches for discovery, process development and cGMP-compatible manufacturing.
Processing assemblies and reagents
Disposable and reusable consumable assemblies and buffer formulations intended to support desired scale and throughput for electroporation workflows.
Flow Electroporation
Clinically validated and cGMP compliant flow electroporation technology capable of transfecting up to 20 billion cells.
FLOW ELECTROPORATION Processing Assembly, Research Grade, 5 mL to 20 mL volume
Flow electroporation processing assembly, research grade, 5 mL to 20 mL volume, sample and collection PVC bags with luer locking syringe ports, closed system, bioweldable tubing, single pack.
CL-2
Transfect up to 20 billion cells in less than 30 minutes with this Flow Electroporation enabled processing assembly.
CL-2 GMP
Flow Electroporation enabled processing assembly for clinical production up to 100 mL working volume.
Electroporation instruments (static and flow platforms)
Laboratory and manufacturing instruments enabling transfection of primary cells, cell lines and large cell batches for discovery, process development and cGMP-compatible manufacturing.
Processing assemblies and reagents
Disposable and reusable consumable assemblies and buffer formulations intended to support desired scale and throughput for electroporation workflows.
Flow Electroporation
Clinically validated and cGMP compliant flow electroporation technology capable of transfecting up to 20 billion cells.
FLOW ELECTROPORATION Processing Assembly, Research Grade, 5 mL to 20 mL volume
Flow electroporation processing assembly, research grade, 5 mL to 20 mL volume, sample and collection PVC bags with luer locking syringe ports, closed system, bioweldable tubing, single pack.
CL-2
Transfect up to 20 billion cells in less than 30 minutes with this Flow Electroporation enabled processing assembly.
CL-2 GMP
Flow Electroporation enabled processing assembly for clinical production up to 100 mL working volume.
Services
Provision of static and flow electroporation instruments, optimization support, training, and field application services for research and manufacturing customers.
Contract laboratory services providing nomination and confirmation sequencing assays to identify and prioritize editing-related risks for genome editing programs, including workflows applicable to base editors.
Regulatory filing support leveraging maintained regulatory technical files, audit readiness assistance, validation guidance and on-site compliance support for manufacturing operations.
In-person and virtual seminars and workshops covering scalable electroporation, genome editing workflows, process development and case studies in cell engineering for academic and industry researchers.
Provision of static and flow electroporation instruments, optimization support, training, and field application services for research and manufacturing customers.
Contract laboratory services providing nomination and confirmation sequencing assays to identify and prioritize editing-related risks for genome editing programs, including workflows applicable to base editors.
Regulatory filing support leveraging maintained regulatory technical files, audit readiness assistance, validation guidance and on-site compliance support for manufacturing operations.
In-person and virtual seminars and workshops covering scalable electroporation, genome editing workflows, process development and case studies in cell engineering for academic and industry researchers.
Expertise Areas
- Cell and gene therapy process development
- Non-viral transfection and electroporation
- Genome-editing off-target detection and confirmation
- GMP-compatible manufacturing support and consumables
Key Technologies
- Non-viral electroporation (static and flow)
- High-throughput multiwell electroporation
- Ribonucleoprotein (RNP) delivery
- Single-stranded HDR template delivery
News & Updates
In-person seminar on scalable cell engineering and gene editing workflows with academic and industry speakers, covering primary cell, stem cell and cell line engineering and case studies.
Seminar presenting electroporation-enabled process development and case studies for non-viral cell engineering and CRISPR-based manufacturing approaches.
In-person and virtual seminar highlighting non-viral cell engineering and clinical-scale manufacturing workflows, including presentations from academic GMP facility leaders.
On-demand seminar covering scalable electroporation platform applications, including CRISPR, protein production and viral production case studies.
Webinar showcasing non-viral CAR-NK cell engineering approaches and process development case studies enabling clinical advancement.
Announcement describing expansion of off-target nomination methods to support base editor assessment and related sequencing workflows.
In-person seminar on scalable cell engineering and gene editing workflows with academic and industry speakers, covering primary cell, stem cell and cell line engineering and case studies.
Seminar presenting electroporation-enabled process development and case studies for non-viral cell engineering and CRISPR-based manufacturing approaches.
In-person and virtual seminar highlighting non-viral cell engineering and clinical-scale manufacturing workflows, including presentations from academic GMP facility leaders.
On-demand seminar covering scalable electroporation platform applications, including CRISPR, protein production and viral production case studies.
Webinar showcasing non-viral CAR-NK cell engineering approaches and process development case studies enabling clinical advancement.
Announcement describing expansion of off-target nomination methods to support base editor assessment and related sequencing workflows.